Nuzenio

Intranasal Foralumab

Intranasal Foralumab news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

organization 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:20:12 GMT Tiziana Life Sciences (Nasdaq: TLSA) CEO boosts stake with 321,423-share buy - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:26 GMT Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 11:30:00 GMT Tiziana’s foralumab reduces brain inflammation in MSA patients - The Pharma LetterThe Pharma Letter · Mon, 03 Aug 2026 07:30:35 GMT Tiziana Reports Reduction in Brain Inflammation in Third - GlobeNewswireGlobeNewswire · Fri, 31 Jul 2026 11:00:00 GMT Tiziana reports up to 34% drop in brain inflammation in third MSA patient on intranasal foralumab in Phase 2 trial - BitgetBitget · Fri, 31 Jul 2026 03:04:50 GMT

Timeline

Thu, 06 Aug 2026 11:20:12 GMTTiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer - The Manila Times

Thu, 06 Aug 2026 11:00:26 GMTTiziana Life Sciences (Nasdaq: TLSA) CEO boosts stake with 321,423-share buy - Stock Titan

Wed, 05 Aug 2026 11:30:00 GMTTiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses - The Globe and Mail

Mon, 03 Aug 2026 07:30:35 GMTTiziana’s foralumab reduces brain inflammation in MSA patients - The Pharma Letter

Fri, 31 Jul 2026 11:00:00 GMTTiziana Reports Reduction in Brain Inflammation in Third - GlobeNewswire

Fri, 31 Jul 2026 03:04:50 GMTTiziana reports up to 34% drop in brain inflammation in third MSA patient on intranasal foralumab in Phase 2 trial - Bitget

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Tiziana Life Sciences4 live mentions MSA4 live mentions The Manila Times3 live mentions Tiziana3 live mentions The Pharma Letter3 live mentions Announces Purchase2 live mentions Shares2 live mentions Chief Executive Officer2 live mentions Nasdaq2 live mentions TLSA2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Intranasal Foralumab.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.